Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / HJLI - Hancock Jaffe Laboratories: Developing Nature-Mimetic Bioprosthetics

HJLI - Hancock Jaffe Laboratories: Developing Nature-Mimetic Bioprosthetics

Hancock Jaffe Laboratories Inc.
  • Hancock Jaffe Laboratories develops nature-mimetic bioprosthetics for patients with debilitating cardiovascular diseases.
  • The Company got IDE approval in April 2021 to begin a pivotal trial of VenoValve in the U.S.
  • FDA granted Breakthrough Device Designation to the Company’s VenoValve in August 2021.
  • The Company recently entered into an at-the-market agreement to sell up to $25 million shares of common stock.

For further details see:

Hancock Jaffe Laboratories: Developing Nature-Mimetic Bioprosthetics
Stock Information
Company Name: Hancock Jaffe Laboratories Inc.
Stock Symbol: HJLI
Market: NASDAQ
Menu
HJLI HJLI Quote HJLI Short HJLI News HJLI Articles HJLI Message Board
Get HJLI Alerts

News, Short Squeeze, Breakout and More Instantly...